This study addresses the key roles of grp94, a major molecular chaperone in the endoplasmic reticulum (ER) in plasma cell biology and multiple myeloma (MM). MM is an incurable plasma cell neoplasm whose pathogenesis is closely linked to dysregulated unfolded protein response (UPR) in the ER. Constitutive activation of UPR in mice, as demonstrated by transgenic expression of a master UPR transcription factor XBP1s (a UPR-specific splice variant of X-box binding protein 1), causes myeloma. However, the underlying mechanism remains unknown. We have demonstrated that grp94 is an obligate chaperone for Wnt co-receptor low-density lipoprotein receptor-related protein 6 (LRP6). Furthermore, the persistence of plasma cells, as well as the development of myeloma in XBP1s-transgenic mice is critically dependent on grp94. The addiction of myeloma cells to grp94 was also demonstrated genetically and pharmacologically using multiple human myeloma cell lines. Furthermore, we found that grp94 is highly expressed in malignant plasma cells in MM. The higher level of grp94 is significantly associated with a worse clinical stage in MM. Thus, we hypothesize that the pathogenesis of MM is driven by both dysregulated UPR and canonical Wnt signaling, both of which converges onto grp94. We will address this hypothesis in Specific Aim 1, by taking advantage of multiple unique genetic tools we have generated including B cell-specific grp94 knockout mice and B cell-specific ?-catenin knockout mice.
In Specific Aim 2, we will determine the roles of grp94 in the full clinical manifestation of myeloma in both novel MM mouse models and xenogenic human myeloma model. Moreover, in collaboration with Dr. Gabriela Chiosis from Sloan-Kettering Institute for Cancer Research, a novel class of grp94-specific inhibitors will be developed and investigated for their preclinical efficacy against myeloma. Overall, our studies will not only provide fundamental new insights into the roles of grp94 in the pathogenesis of MM, but also be instrumental in the development of grp94-targeted therapeutics against this disease.

Public Health Relevance

Multiple myeloma is an incurable plasma cell neoplasm. This work aims to understand the mechanism of multiple myeloma by focusing on a key regulatory protein called grp94. A grp94-directed 'drug-like' inhibitor will be developed as a novel treatment of this disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA193939-02
Application #
9247163
Study Section
Molecular and Cellular Hematology Study Section (MCH)
Program Officer
Howcroft, Thomas K
Project Start
2016-04-01
Project End
2021-03-31
Budget Start
2017-04-01
Budget End
2018-03-31
Support Year
2
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29403
Thaxton, Jessica E; Wallace, Caroline; Riesenberg, Brian et al. (2017) Modulation of Endoplasmic Reticulum Stress Controls CD4+ T-cell Activation and Antitumor Function. Cancer Immunol Res 5:666-675
Hong, Feng; Liu, Bei; Wu, Bill X et al. (2017) CNPY2 is a key initiator of the PERK-CHOP pathway of the unfolded protein response. Nat Struct Mol Biol 24:834-839
Hong, Feng; Mohammad Rachidi, Saleh; Lundgren, Debbie et al. (2017) Mapping the Interactome of a Major Mammalian Endoplasmic Reticulum Heat Shock Protein 90. PLoS One 12:e0169260
Hua, Yunpeng; Yang, Yi; Sun, Shaoli et al. (2017) Gut homeostasis and regulatory T cell induction depend on molecular chaperone gp96 in CD11c+ cells. Sci Rep 7:2171
Ansa-Addo, Ephraim A; Zhang, Yongliang; Yang, Yi et al. (2017) Membrane-organizing protein moesin controls Treg differentiation and antitumor immunity via TGF-? signaling. J Clin Invest 127:1321-1337
Rachidi, Saleh; Metelli, Alessandra; Riesenberg, Brian et al. (2017) Platelets subvert T cell immunity against cancer via GARP-TGF? axis. Sci Immunol 2:
Metelli, Alessandra; Wu, Bill X; Fugle, Caroline W et al. (2016) Surface Expression of TGF? Docking Receptor GARP Promotes Oncogenesis and Immune Tolerance in Breast Cancer. Cancer Res 76:7106-7117
Ansa-Addo, Ephraim A; Thaxton, Jessica; Hong, Feng et al. (2016) Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94. Curr Top Med Chem 16:2765-78
Fugle, Caroline W; Zhang, Yongliang; Hong, Feng et al. (2016) CD24 blunts oral squamous cancer development and dampens the functional expansion of myeloid-derived suppressor cells. Oncoimmunology 5:e1226719